Drug profile · INN
hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)
AMBIRIX
hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed) (AMBIRIX) is a surface antigen (hbsag) vaccine antigen.
EMA: approved Antiinfectives for systemic use (J07) J07BC20
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 7
- Data quality
- 0.83
Quick answer
hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed) (AMBIRIX) is a surface antigen (hbsag) vaccine antigen.
Key facts
INN hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)
Brand AMBIRIX
Mechanism Surface antigen (HBsAg) vaccine antigen
Target Surface antigen (HBsAg)
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BC20
Mechanism of action
Surface antigen (HBsAg) vaccine antigen
Primary target: Surface antigen (HBsAg)
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)?
hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed) (AMBIRIX) is a surface antigen (hbsag) vaccine antigen.
What is the brand name for hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)?
AMBIRIX is a marketed brand name for hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.